Fig. 1From: Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cellsABC transporters decrease intracellular drug concentration conferring MDR. Cancer cells promote overexpression or activation of ABC transporter, enhancing the efflux of chemotherapeutic drugs, which leads to a lower intracellular drug concentration and results in MDR phenotypeBack to article page